LINC01410 and cancer: LINC01410 is markedly upregulated in osteosarcoma (OS) cells and tissues, where it downregulates miR-122-5p, miR-497-5p, and miR-3128 while upregulating the expression of NDRG3 and HMGA2, thereby promoting OS cell proliferation, invasion, and migration (15–17).In neuroblastoma, LINC01410 acts as a sponge for miR-506-3p and miR-545-3p, respectively upregulating WEE1 and HK2, thereby promoting cancer cell proliferation, invasion, and migration, inhibiting apoptosis and cell cycle progression, and reducing radiosensitivity (25, 26).